Streetbeat News

Stock Prices

MRO

Goldman Sachs analyst Neil Mehta has upgraded Marathon Oil Corp (NYSE:MRO) from Sell to Neutral with a $25 price target. The upgrade is based on the potential for strong free cash flow growth and returns to shareholders. MRO is expected to generate strong free cash flow over the next 3-4 years, supported by stable production profile, and uplift from Equatorial Guinea driven by exposure to international gas pricing. MRO shares traded higher by 1.73% at $24.75 on the last check Wednesday.

Portfolio Pulse from Anusuya Lahiri

July 12, 2023 | 5:29 pm

ADBE

AMZN

Amazon's Prime Day sales reached $6.4 billion in the first 24 hours, a 6% increase year-on-year, despite consumer spending falling short of estimates. The average order size was $56.64, up 7% Y/Y. Home goods and household essentials were the best-selling categories. Adobe and Insider Intelligence had previously estimated the Y/Y sales to rise between 9.5% - 11%.

Portfolio Pulse from Anusuya Lahiri

July 12, 2023 | 5:24 pm

DAKT

Daktronics (DAKT) shares are trading higher following the company's better-than-expected Q4 results.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:22 pm

DAKT

Daktronics (DAKT) shares are trading higher following the company's better-than-expected Q4 results.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:20 pm

GOLD

A significant bullish stance has been taken on Barrick Gold (NYSE:GOLD) as evidenced by unusual options activity. The options scanner at Benzinga spotted 12 uncommon trades for Barrick Gold, split between 50% bullish and 50% bearish. The total amount for puts is $232,954 and for calls is $353,330. Whales have been targeting a price range from $15.0 to $22.0 for Barrick Gold over the last 3 months. The price of GOLD is up 4.5% at $17.46.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 5:19 pm

MRNA

A large bearish position on Moderna (NASDAQ:MRNA) has been noticed, with 15 uncommon options trades spotted. The sentiment of these big-money traders is split between 46% bullish and 53% bearish. Whales have been targeting a price range from $100.0 to $165.0 for Moderna over the last 3 months. UBS upgraded its action to Buy with a price target of $191, while Morgan Stanley maintained their Equal-Weight rating with a price target of $128.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 5:19 pm

IEP

Icahn Enterprises shares are trading lower, possibly due to a pullback after Monday's gains.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:13 pm

CSCO

Bank of America Securities has downgraded Cisco Systems from Buy to Neutral, leading to a decrease in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:06 pm

ELV

Elevance Health's stock has been downgraded from Outperform to Peer Perform by Wolfe Research, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:04 pm

PRFX

PainReform announced the pricing of a $2.7 million concurrent registered direct offering and private placement, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 5:02 pm